Stocks · Health care · Biological Products, (No Diagnostic Substances)

Relay Therapeutics, Inc.

RLAY Clue Score52

United States Fiscal year ends December CIK 0001812364 Results filed 4 Nov 2026

Add to watchlist

What the insiders did Net selling

By person

15 insiders · 278 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Third Rock Ventures III, L.P. entity

10% owner

—

$227.13M (12)

−$227.13M

7,739,918

3.53%

$144.12M

+1,274%

SVF Pauling (Cayman) Ltd entity

10% owner

—

$116.40M (1)

−$116.40M

21,904,963

10.00%

$407.87M

—

Sanjiv Patel

President and CEO

$500.00K (1)

$16.73M (38) scheduled

−$16.23M

1,557,752

0.7108%

$29.01M

+1.5%

Donald A Bergstrom

President, R&D

—

$12.14M (63) scheduled

−$12.14M

396,878

0.1811%

$7.39M

+2,248%

Thomas Catinazzo

Chief Financial Officer

—

$10.79M (69) scheduled

−$10.79M

103,665

0.0473%

$1.93M

—

Peter Rahmer

See remarks

—

$3.13M (42) scheduled

−$3.13M

222,904

0.1017%

$4.15M

+1,770%

Brian Adams

Chief Legal Officer

$200.00K (1)

$2.00M (39) scheduled

−$1.80M

371,472

0.1695%

$6.92M

—

Douglas S Ingram

Director

$500.00K (1)

—

+$500.00K

25,000

0.0114%

$465.50K

—

Jami Rubin

Director

$500.00K (1)

—

+$500.00K

67,242

0.0307%

$1.25M

—

Mark Murcko

Director

$500.00K (1)

$748.75K (1)

−$248.75K

996,952

0.4549%

$18.56M

+128.4%

Andy Porter

Chief Administrative Officer

—

$59.04K (7)

−$59.04K

45,164

0.0206%

$840.95K

+93.0%

Picularium, LLC entity

10% owner

—

—

—

3,281,253

1.50%

$61.10M

—

Alexandria Venture Investments, LLC entity

10% owner

—

—

—

968,365

0.4419%

$18.03M

—

Alexis Borisy

Director

—

—

—

234,175

0.1069%

$4.36M

—

Laura Shawver

Director

—

—

—

40,000

0.0183%

$744.80K

−23.2%